Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Cryoablation increases survival rates in ovarian cancer patients

Ovarian cancer, which killed 15,000 American women last year, is one of the deadliest forms of cancer. A team of Wayne State University School of Medicine researchers recently proved that freezing tumors increases survival rates in ovarian cancer patients.

17 Feb 2012

BioCryst fourth quarter revenues decrease to $5.2 million

BioCryst Pharmaceuticals, Inc. announced financial results for the fourth quarter and full year ended December 31, 2011.

16 Feb 2012

Controversy over psychiatric diagnosis reaches a fever pitch

As the Diagnostic and Statistical Manual of Mental Disorders is revised for the first time since 1994, controversy about psychiatric diagnosis is reaching a fever pitch.

16 Feb 2012

Reuters examines upcoming WHO meeting to discuss debate over bird flu research

Bird flu experts are scheduled to begin a two-day meeting at the WHO in Geneva on Thursday "to try to settle an unprecedented row over a call to censor publication of two scientific studies which detail how to mutate H5N1 bird flu viruses into a form that could cause a deadly human pandemic," Reuters reports in an article describing the debate in detail.

16 Feb 2012

Amoxicillin not effective for patients with acute rhinosinusitis

Treatment with the antibiotic amoxicillin for patients with acute uncomplicated rhinosinusitis (inflammation of the nasal cavity and sinuses) did not result in a significant difference in symptoms compared to patients who received placebo, according to a study in the February 15 issue of JAMA. Antibiotics are commonly used to treat this condition even though there is limited evidence supporting their effectiveness.

15 Feb 2012

Bird flu controversy an opportunity to set a higher tone for public debate

In this Huffington Post opinion piece, Leslie Gerwin, associate director of law and public affairs at Princeton University, reflects on the recent controversy over whether to research and publish data about potentially dangerous strains of the H5N1 bird flu virus, writing, "I am disturbed that so much coverage of this dispute -- so deserving of sober consideration -- is fixated on fear mongering."

15 Feb 2012

Antibiotic prescriptions do not reduce sinus symptoms

Antibiotics that doctors typically prescribe for sinus infections do not reduce symptoms any better than an inactive placebo, according to investigators at Washington University School of Medicine in St. Louis.

15 Feb 2012

GAO finds big disparities in prices of some medical devices

News outlets examine a variety of health workplace issues, including a GAO report on medical device prices and efforts to get health workers vaccinated for the flu.

14 Feb 2012

Shortage of primary care doctors raises concerns

As the administration moves toward implementation of the health law, officials are seeking to bolster the number of primary care doctors. Also, hospitals are concerned about a possible measurement that would grade their efforts on patient safety.

14 Feb 2012

FDA requests a budget of $4.5 billion to protect and promote public health

The U.S. Food and Drug Administration is requesting a budget of $4.5 billion to protect and promote the public health as part of the President's fiscal year (FY) 2013 budget – a 17 percent increase over the FDA enacted budget for FY 2012.

14 Feb 2012

Compound makes imipenem 16 times more effective against antibiotic-resistant K. pneumoniae

North Carolina State University chemists have created a compound that makes existing antibiotics 16 times more effective against recently discovered antibiotic-resistant "superbugs."

14 Feb 2012

InComm announces acquisition of Medagate

InComm, a leading prepaid product and transaction services company, announced today that it has acquired Medagate Corporation, the company that powers OTCNetwork, the only national closed loop over-the-counter (OTC) healthcare benefits payments platform.

13 Feb 2012

DARPA awards fourth milestone payment of $3.56M to Medicago

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.

13 Feb 2012

First Edition: February 13, 2012

Today's early morning highlights from the major news organizations preview President Barack Obama's budget, which will be released today, and examine the lingering controversy over mandates on contraceptive coverage.

13 Feb 2012

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Regeneron Pharmaceuticals, Inc. announced financial and operating results for the fourth quarter and full year 2011 and provided an update on development programs.

13 Feb 2012

WHO convening meeting in one week to explore opinions surrounding H5N1 bird flu research

NPR's health blog "Shots" previews an upcoming WHO-convened meeting to discuss the recent news that two research teams have created H5N1 bird flu strains that are easily transmissible among ferrets, which are used as lab models for humans.

13 Feb 2012

Grand Challenges Canada, Gates Foundation announce grants for innovative Global Health projects

"Grand Challenges Canada on Thursday announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions," according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges.

13 Feb 2012

UofL to receive Grand Challenges tuberculosis biomarkers grant

The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."

10 Feb 2012

Forsyth Institute to receive TB biomarkers grant from Gates Foundation

The Forsyth Institute announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.

10 Feb 2012

Grand Challenges Canada announces 15 grants to support rising stars in global health

Grand Challenges Canada today announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions.

10 Feb 2012